RU2012105901A - Способы снижения потери функционального состояния - Google Patents
Способы снижения потери функционального состояния Download PDFInfo
- Publication number
- RU2012105901A RU2012105901A RU2012105901/15A RU2012105901A RU2012105901A RU 2012105901 A RU2012105901 A RU 2012105901A RU 2012105901/15 A RU2012105901/15 A RU 2012105901/15A RU 2012105901 A RU2012105901 A RU 2012105901A RU 2012105901 A RU2012105901 A RU 2012105901A
- Authority
- RU
- Russia
- Prior art keywords
- bcaa
- whey protein
- vitamin
- protein
- therapeutic nutrition
- Prior art date
Links
- 108010046377 Whey Proteins Proteins 0.000 claims abstract 25
- 238000000034 method Methods 0.000 claims abstract 25
- 235000016709 nutrition Nutrition 0.000 claims abstract 24
- 230000035764 nutrition Effects 0.000 claims abstract 24
- 102000007544 Whey Proteins Human genes 0.000 claims abstract 22
- 235000021119 whey protein Nutrition 0.000 claims abstract 22
- 230000001225 therapeutic effect Effects 0.000 claims abstract 21
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract 16
- 235000018102 proteins Nutrition 0.000 claims abstract 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract 13
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract 12
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims abstract 12
- 150000005693 branched-chain amino acids Chemical class 0.000 claims abstract 12
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract 12
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract 12
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract 12
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims abstract 12
- 235000019136 lipoic acid Nutrition 0.000 claims abstract 12
- 229960002663 thioctic acid Drugs 0.000 claims abstract 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract 11
- 239000011718 vitamin C Substances 0.000 claims abstract 11
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract 9
- 239000000693 micelle Substances 0.000 claims abstract 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract 8
- SXZYCXMUPBBULW-FORAYFFESA-N (5r)-5-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)C1O SXZYCXMUPBBULW-FORAYFFESA-N 0.000 claims abstract 6
- LVRFTAZAXQPQHI-UHFFFAOYSA-N 2-hydroxy-4-methylvaleric acid Chemical compound CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 claims abstract 6
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims abstract 6
- BKAJNAXTPSGJCU-UHFFFAOYSA-N 4-methyl-2-oxopentanoic acid Chemical compound CC(C)CC(=O)C(O)=O BKAJNAXTPSGJCU-UHFFFAOYSA-N 0.000 claims abstract 6
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims abstract 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract 6
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims abstract 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims abstract 6
- 244000269722 Thea sinensis Species 0.000 claims abstract 6
- 239000003963 antioxidant agent Substances 0.000 claims abstract 6
- 235000006708 antioxidants Nutrition 0.000 claims abstract 6
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract 6
- 150000001875 compounds Chemical class 0.000 claims abstract 6
- 229920002770 condensed tannin Polymers 0.000 claims abstract 6
- 229960003624 creatine Drugs 0.000 claims abstract 6
- 239000006046 creatine Substances 0.000 claims abstract 6
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims abstract 6
- 235000006539 genistein Nutrition 0.000 claims abstract 6
- 229940045109 genistein Drugs 0.000 claims abstract 6
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims abstract 6
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims abstract 6
- 235000009569 green tea Nutrition 0.000 claims abstract 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract 6
- 150000002614 leucines Chemical class 0.000 claims abstract 6
- 235000012661 lycopene Nutrition 0.000 claims abstract 6
- 229960004999 lycopene Drugs 0.000 claims abstract 6
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract 6
- 239000001751 lycopene Substances 0.000 claims abstract 6
- 239000002207 metabolite Substances 0.000 claims abstract 6
- 239000002773 nucleotide Substances 0.000 claims abstract 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract 6
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract 6
- 239000002243 precursor Substances 0.000 claims abstract 6
- 229940106796 pycnogenol Drugs 0.000 claims abstract 6
- 235000005875 quercetin Nutrition 0.000 claims abstract 6
- 229960001285 quercetin Drugs 0.000 claims abstract 6
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims abstract 6
- 229960001295 tocopherol Drugs 0.000 claims abstract 6
- 239000011732 tocopherol Substances 0.000 claims abstract 6
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract 6
- 229940035936 ubiquinone Drugs 0.000 claims abstract 6
- 229930003316 Vitamin D Natural products 0.000 claims abstract 5
- 230000037081 physical activity Effects 0.000 claims abstract 5
- 229940088594 vitamin Drugs 0.000 claims abstract 5
- 229930003231 vitamin Natural products 0.000 claims abstract 5
- 235000013343 vitamin Nutrition 0.000 claims abstract 5
- 239000011782 vitamin Substances 0.000 claims abstract 5
- 235000019166 vitamin D Nutrition 0.000 claims abstract 5
- 239000011710 vitamin D Substances 0.000 claims abstract 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract 5
- 229940046008 vitamin d Drugs 0.000 claims abstract 5
- 230000000975 bioactive effect Effects 0.000 claims abstract 3
- 239000012141 concentrate Substances 0.000 claims abstract 3
- 210000003205 muscle Anatomy 0.000 claims abstract 3
- 235000021466 carotenoid Nutrition 0.000 claims abstract 2
- 150000001747 carotenoids Chemical class 0.000 claims abstract 2
- 230000004220 muscle function Effects 0.000 claims abstract 2
- 208000001076 sarcopenia Diseases 0.000 claims abstract 2
- 235000013305 food Nutrition 0.000 claims 11
- 239000000203 mixture Substances 0.000 claims 11
- 235000005282 vitamin D3 Nutrition 0.000 claims 4
- 239000011647 vitamin D3 Substances 0.000 claims 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 4
- 229940021056 vitamin d3 Drugs 0.000 claims 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 3
- 229930003779 Vitamin B12 Natural products 0.000 claims 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 3
- 229940014144 folate Drugs 0.000 claims 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 3
- 235000019152 folic acid Nutrition 0.000 claims 3
- 239000011724 folic acid Substances 0.000 claims 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 3
- 239000011777 magnesium Substances 0.000 claims 3
- 229910052749 magnesium Inorganic materials 0.000 claims 3
- 239000011707 mineral Substances 0.000 claims 3
- 235000019163 vitamin B12 Nutrition 0.000 claims 3
- 239000011715 vitamin B12 Substances 0.000 claims 3
- 239000011701 zinc Substances 0.000 claims 3
- 229910052725 zinc Inorganic materials 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 244000241838 Lycium barbarum Species 0.000 claims 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims 2
- 235000004251 balanced diet Nutrition 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 2
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 2
- 239000006014 omega-3 oil Substances 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 1
- 108010012715 Superoxide dismutase Proteins 0.000 claims 1
- 230000003542 behavioural effect Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 229960003067 cystine Drugs 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000036542 oxidative stress Effects 0.000 claims 1
- 238000001243 protein synthesis Methods 0.000 claims 1
- 230000014616 translation Effects 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22680609P | 2009-07-20 | 2009-07-20 | |
| US61/226,806 | 2009-07-20 | ||
| US33424710P | 2010-05-13 | 2010-05-13 | |
| US61/334,247 | 2010-05-13 | ||
| PCT/US2010/042083 WO2011011252A1 (en) | 2009-07-20 | 2010-07-15 | Methods of attenuating the loss of functional status |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012105901A true RU2012105901A (ru) | 2013-08-27 |
Family
ID=42990259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012105901/15A RU2012105901A (ru) | 2009-07-20 | 2010-07-15 | Способы снижения потери функционального состояния |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120195873A1 (enExample) |
| EP (2) | EP3231435A1 (enExample) |
| JP (1) | JP2012533627A (enExample) |
| CN (1) | CN102647990A (enExample) |
| AU (1) | AU2010274125B2 (enExample) |
| BR (1) | BR112012001488A2 (enExample) |
| CA (1) | CA2768471A1 (enExample) |
| IN (1) | IN2012DN00486A (enExample) |
| MX (1) | MX2012000943A (enExample) |
| RU (1) | RU2012105901A (enExample) |
| SG (1) | SG177664A1 (enExample) |
| WO (1) | WO2011011252A1 (enExample) |
| ZA (1) | ZA201201229B (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012023025B1 (pt) * | 2010-03-12 | 2021-06-01 | Société des Produits Nestlé S.A. | Composição nutricional, e método para mascarar sabores estranhos de leucina na mesma |
| WO2011139621A1 (en) * | 2010-04-26 | 2011-11-10 | Nestec S.A. | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
| WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
| CA2828134A1 (en) * | 2011-02-25 | 2012-08-30 | Merck Patent Gmbh | Composition to increase joint and/or postural stability |
| CA2831165A1 (en) * | 2011-04-18 | 2012-10-26 | Nestec S.A. | Nutritional compositions having .alpha.-hica and citrulline and methods of using same |
| CA2836241A1 (en) * | 2011-06-08 | 2012-12-13 | Nestec S.A. | Nutritional compositions having exogenous milk fat globule membrane components |
| JP2013051920A (ja) * | 2011-09-05 | 2013-03-21 | Ishikawa Prefectural Public Univ Corp | 骨密度強化補助食品 |
| EP2580967A1 (en) | 2011-10-11 | 2013-04-17 | Nestec S.A. | Accelerating muscle recovery after immobilization-induced muscle atrophy |
| EP2583565A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for enhancing energy expenditure and satiety |
| EP2583563A1 (en) * | 2011-10-21 | 2013-04-24 | Nestec S.A. | Whey protein micelles against muscle atrophy and sarcopenia |
| PL2583566T3 (pl) * | 2011-10-21 | 2016-01-29 | Nestec Sa | Micele serwatkowego białka do zwiększania masy mięśni i sprawności |
| RU2016109981A (ru) * | 2012-01-03 | 2018-11-26 | Нестек С.А. | Композиции и способы для стабильности реакционноспособных аминокислот в пищевом матриксе |
| RU2520036C2 (ru) * | 2012-03-01 | 2014-06-20 | Общество с ограниченной ответственностью "Институт новых технологий" | Пищевой продукт "миоактив-спорт" для питания людей, подверженных интенсивным физическим нагрузкам |
| WO2014055905A1 (en) | 2012-10-04 | 2014-04-10 | Abbott Laboratories | Methods for enhancing the effect of egcg on mitigating skeletal muscle loss |
| CN103783532B (zh) * | 2012-10-29 | 2016-06-08 | 杭州纽曲星生物科技有限公司 | 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法 |
| CN103271350B (zh) * | 2013-03-04 | 2014-09-24 | 中国航天员科研训练中心 | 空间站航天员太空高能压缩食品及其制法 |
| WO2014152606A2 (en) | 2013-03-14 | 2014-09-25 | Abbott Laboratories | Treatment of insulin resistance associated with prolonged physical inactivity |
| MX2015013000A (es) | 2013-03-15 | 2015-12-01 | Abbott Lab | Metodos de mantenimiento y mejora de la funcion muscular. |
| BR112015025490B1 (pt) * | 2013-04-15 | 2022-05-03 | Société des Produits Nestlé S.A. | Uso de uma fonte de aminoácidos em combinação com o estímulo muscular elétrico |
| BR112015027563A2 (pt) * | 2013-05-01 | 2017-07-25 | Abbott Lab | métodos para melhorar a regeneração do músculo envelhecido |
| WO2014191856A1 (en) * | 2013-05-31 | 2014-12-04 | Nestec S.A. | Methods for enhancement of muscle protein synthesis |
| CN112931879A (zh) | 2013-06-10 | 2021-06-11 | N·V·努特里奇亚 | 超重或肥胖成年人在体重减轻项目期间的肌肉保持 |
| JP6279851B2 (ja) * | 2013-07-19 | 2018-02-14 | 雪印メグミルク株式会社 | 筋萎縮防止及び／又は筋合成促進剤 |
| WO2016012403A1 (en) * | 2014-07-21 | 2016-01-28 | Nestec S.A. | Nutritional products to promote safe swallowing for individuals with dysphagia |
| DK3006027T3 (en) * | 2014-10-08 | 2017-12-18 | Professional Dietetics Spa | Compositions comprising amino acids for use in the treatment of systemic inflammation associated with stroke in dysphagia patients |
| CN106793806A (zh) * | 2014-10-14 | 2017-05-31 | 雀巢产品技术援助有限公司 | 对老年男性的肌肉功能的改善 |
| ES2727660T3 (es) * | 2014-11-19 | 2019-10-17 | Nestle Sa | Uso de complejos de micelas de proteína de suero y pectina para controlar el peso corporal |
| AU2016358033A1 (en) * | 2015-11-20 | 2018-04-12 | Société des Produits Nestlé S.A. | Methods using whey protein to improve or maintain muscle quality |
| SG11201804602SA (en) * | 2015-12-03 | 2018-06-28 | Meiji Co Ltd | Nutritional composition |
| CN115919889A (zh) * | 2015-12-22 | 2023-04-07 | 雀巢产品有限公司 | 用于治疗肌肉减少症和虚弱的方法 |
| TW201808120A (zh) * | 2016-03-16 | 2018-03-16 | 味之素股份有限公司 | 行動體力提升劑 |
| CA3020087A1 (en) * | 2016-04-14 | 2017-10-19 | Michael LUCEY | Combinational compositions and methods of use thereof |
| JP6948103B2 (ja) * | 2016-04-14 | 2021-10-13 | 株式会社明治 | フレイル改善用組み合わせ物 |
| AU2017270131B2 (en) * | 2016-05-27 | 2023-03-09 | Société des Produits Nestlé S.A. | Nutritional composition for treating or preventing impaired mobility |
| BR112019009757B1 (pt) * | 2016-11-16 | 2022-12-20 | Fresenius Kabi Deutschland Gmbh | Pufa, vitamina e, vitamina d e os aminoácidos ligados às proteínas glicina, arginina e triptofano, seu uso na fabricação de uma composição nutricional para tratar sarcopenia e/ou fraqueza e composição nutricional |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CA3052324C (en) | 2017-03-03 | 2020-11-03 | Exerkine Corporation | Multi-nutrient composition |
| WO2018221526A1 (ja) * | 2017-06-01 | 2018-12-06 | 株式会社明治 | 栄養組成物 |
| MA49906A (fr) | 2017-08-14 | 2020-06-24 | Axcella Health Inc | Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie |
| EP3810123A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| JP7044306B2 (ja) * | 2018-07-31 | 2022-03-30 | ユーハ味覚糖株式会社 | ロイシン血中濃度上昇促進剤及びその用途 |
| AU2019400099B2 (en) * | 2018-12-13 | 2025-05-22 | Société des Produits Nestlé S.A. | Liquid concentrates formulated for dilution into nutritional products to promote safe swallowing for individuals with dysphagia |
| US12186359B2 (en) | 2019-06-28 | 2025-01-07 | Dompé Farmaceutici S.P.A. | Composition containing branched-chain amino acids |
| JP7655224B2 (ja) * | 2019-10-25 | 2025-04-02 | 味の素株式会社 | 筋質向上剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2683492B2 (ja) * | 1993-09-07 | 1997-11-26 | 雪印乳業株式会社 | ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法 |
| CN1101810A (zh) * | 1994-08-23 | 1995-04-26 | 谢宝兴 | 茯苓枸杞子口服液饮料袋泡茶及其生产方法 |
| EP1062876A1 (en) * | 1999-02-25 | 2000-12-27 | Societe Des Produits Nestle S.A. | Caseinoglycomacropeptides as calcification agent |
| US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
| US7794770B2 (en) * | 2004-10-07 | 2010-09-14 | Next Proteins, Inc. | Protein beverage and method of making the same |
| US20060198899A1 (en) * | 2005-03-01 | 2006-09-07 | Gardiner Paul T | Supplemental dietary composition for supporting muscle growth, recovery and strength |
| FR2882896B1 (fr) * | 2005-03-14 | 2007-05-04 | Larena Sa | Composition alimentaire pour prevenir le syndrome de fragilite chez les personnes agees |
| US20070020358A1 (en) * | 2005-03-18 | 2007-01-25 | Mower Thomas E | Sports drink concentrate |
| US20070036873A1 (en) | 2005-07-27 | 2007-02-15 | Shibnath Ghosal | Method of treatment or management of stress |
| CA2621739A1 (en) * | 2005-09-09 | 2007-03-15 | Murray Goulburn Co-Operative Co. Limited | Composition of whey growth factor extract for reducing muscle inflammation |
| EP1839495B1 (en) * | 2006-03-27 | 2011-02-02 | Nestec S.A. | Protein-enriched frozen dessert |
| DK1839504T3 (da) * | 2006-03-27 | 2009-06-08 | Nestec Sa | In situ-fremstilling af valleprotein-miceller |
| EP2081450A1 (en) * | 2006-10-19 | 2009-07-29 | Nestec S.A. | Long-term feed - cancer patient |
| AR060847A1 (es) | 2007-05-03 | 2008-07-16 | Spannagel Lucia Antonia | Formulacion a base de calendula, aloe y centella. |
| CA2723441A1 (en) * | 2008-05-21 | 2009-11-26 | Stokely-Van Camp, Inc. | Milk-based recovery beverage |
| WO2010002242A1 (en) * | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
-
2010
- 2010-07-15 BR BR112012001488A patent/BR112012001488A2/pt not_active Application Discontinuation
- 2010-07-15 IN IN486DEN2012 patent/IN2012DN00486A/en unknown
- 2010-07-15 CN CN201080041532XA patent/CN102647990A/zh active Pending
- 2010-07-15 MX MX2012000943A patent/MX2012000943A/es not_active Application Discontinuation
- 2010-07-15 JP JP2012521681A patent/JP2012533627A/ja active Pending
- 2010-07-15 SG SG2012002812A patent/SG177664A1/en unknown
- 2010-07-15 CA CA2768471A patent/CA2768471A1/en not_active Abandoned
- 2010-07-15 WO PCT/US2010/042083 patent/WO2011011252A1/en not_active Ceased
- 2010-07-15 EP EP17164469.3A patent/EP3231435A1/en not_active Withdrawn
- 2010-07-15 EP EP10747335A patent/EP2456448A1/en not_active Withdrawn
- 2010-07-15 US US13/386,209 patent/US20120195873A1/en not_active Abandoned
- 2010-07-15 RU RU2012105901/15A patent/RU2012105901A/ru not_active Application Discontinuation
- 2010-07-15 AU AU2010274125A patent/AU2010274125B2/en not_active Ceased
-
2012
- 2012-02-17 ZA ZA2012/01229A patent/ZA201201229B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2456448A1 (en) | 2012-05-30 |
| AU2010274125A1 (en) | 2012-02-16 |
| US20120195873A1 (en) | 2012-08-02 |
| MX2012000943A (es) | 2012-02-28 |
| CN102647990A (zh) | 2012-08-22 |
| EP3231435A1 (en) | 2017-10-18 |
| AU2010274125B2 (en) | 2015-11-05 |
| JP2012533627A (ja) | 2012-12-27 |
| BR112012001488A2 (pt) | 2019-10-08 |
| WO2011011252A1 (en) | 2011-01-27 |
| IN2012DN00486A (enExample) | 2015-05-22 |
| CA2768471A1 (en) | 2011-01-27 |
| SG177664A1 (en) | 2012-02-28 |
| ZA201201229B (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012105901A (ru) | Способы снижения потери функционального состояния | |
| Cicero et al. | Nutrients and nutraceuticals for the management of high normal blood pressure: an evidence-based consensus document | |
| Borghi et al. | Nutraceuticals with a clinically detectable blood pressure‐lowering effect: a review of available randomized clinical trials and their meta‐analyses | |
| Solak et al. | Health benefits of whey protein: a review | |
| AU2012299126B2 (en) | Compositions and methods for use in promoting lean body mass | |
| CN101484158B (zh) | 衰老抑制剂 | |
| US20080286254A1 (en) | Composition comprising licorice polyphenol | |
| Sirtori et al. | Nutraceuticals for blood pressure control | |
| KR20090037403A (ko) | 노화 억제제 | |
| US9408894B2 (en) | Anti-fatigue composition | |
| CA2498141A1 (en) | Orally administrable composition for improving skin quality | |
| CA2498199A1 (en) | Orally administrable composition for improving hair and coat quality | |
| CN104869848B (zh) | 用多酚增加黄烷-3-醇的生物利用度 | |
| JP6985328B2 (ja) | 代謝活性化剤 | |
| CA2731282C (en) | Anti-fatigue composition | |
| CN103478718B (zh) | 提高人体内谷胱甘肽浓度的功能食品及其制备方法 | |
| JP5854578B2 (ja) | 筋肉増強剤または基礎代謝増強剤 | |
| JP6254434B2 (ja) | 敏捷性改善剤 | |
| JP2012067041A (ja) | Ａｃｅ活性阻害剤 | |
| Mishra et al. | Mineral nutraceuticals and immunity enhancement | |
| Hite et al. | Functional foods: needs, claims, and benefits | |
| Tejas et al. | A review on dietary supplements: Delivery systems, applications and regulations | |
| JP7709913B2 (ja) | 筋肉増強剤 | |
| JP7460327B2 (ja) | 経口組成物 | |
| Blomstrand | Branched chain amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20141119 |